Black race is not protective against hazardous bilirubin levels

Andrea C Wickremasinghe1, Michael W Kuzniewicz, Thomas B Newman

  • 1Department of Pediatrics, University of California, San Francisco, CA 94143, USA. wickremasinghea@peds.ucsf.edu

The Journal of Pediatrics
|February 14, 2013
PubMed

Insights

Black infants have a lower risk of high total serum bilirubin levels but a greater risk of severe hyperbilirubinemia and kernicterus. This challenges the assumption that Black race is protective against severe jaundice in newborns.

Area of Science:

  • Neonatal Medicine
  • Pediatric Hematology
  • Public Health

Background:

  • Hyperbilirubinemia is a common condition in newborns.
  • Black race has been traditionally considered protective against hyperbilirubinemia.
  • Kernicterus, a severe form of newborn jaundice, remains a concern.

Purpose of the Study:

  • To investigate the association between race and the risk of developing severe hyperbilirubinemia.
  • To examine the relationship between race and the incidence of kernicterus in infants.
  • To clarify the protective role of Black race against neonatal jaundice.

Main Methods:

  • Retrospective cohort study.
  • Analysis of large-scale infant health records.
  • Comparison of total serum bilirubin levels between different racial groups.

Main Results:

  • Black infants showed a lower risk of developing total serum bilirubin levels ≥ 20 mg/dL compared to white infants.
  • Black infants demonstrated a significantly higher risk of developing total serum bilirubin levels ≥ 30 mg/dL.
  • Increased risk of kernicterus was observed in Black infants despite lower overall hyperbilirubinemia rates.

Conclusions:

  • The protective effect of Black race against hyperbilirubinemia may be limited to lower bilirubin thresholds.
  • Black infants are at a disproportionately higher risk for severe hyperbilirubinemia (≥ 30 mg/dL) and kernicterus.
  • Clinical management of neonatal jaundice should consider race-specific risk factors for severe outcomes.

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Lifecycle of Erythrocytes01:22

Lifecycle of Erythrocytes

Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...